ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Int J Inflam Cancer Integr Ther 2024, Vol 11(3): 280

Advances in Lung Cancer Biomarkers: Detection and Clinical Application

Annadorai Tamilselvan*
Department of Pathology, Stanford University School of Medicine, USA
*Corresponding Author : Annadorai Tamilselvan, Department of Pathology, Stanford University School of Medicine, USA, Email: Anna_ts@gmail.com

Received Date: May 30, 2024 / Published Date: Jun 26, 2024

Abstract

Lung cancer remains a leading cause of cancer-related mortality worldwide, largely due to late-stage diagnosis and limited therapeutic options. Recent advancements in the identification and utilization of biomarkers have revolutionized lung cancer detection, prognosis, and treatment. This article reviews the current state of lung cancer biomarkers, focusing on their detection methodologies, clinical applications, and future potential in improving patient outcomes.

Citation: Annadorai T (2024) Advances in Lung Cancer Biomarkers: Detection andClinical Application. Int J Inflam Cancer Integr Ther, 11: 280.

Copyright: © 2024 Annadorai T. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top